Olbrich, Carsten,Krause, Michael,Burkhard, Andreas
申请号：
AU2010334929
公开号：
AU2010334929A1
申请日:
2010.12.22
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The invention is directed to formulations of lipophilic Amyloid βeta ligand stilbene based derivatives and more particularly to formulations which are administrable parentally e.g. intravenously wherein the lipophilic Amyloid βeta ligand stilbene based derivative is a F or F-labeled radiopharmaceutical thereof. Further, the invention is directed to a method for sterile filtration of said suitable formulation.
